NRXP
Nrx Pharmaceuticals
$3.63
−$0.12 (−3.2%)Jul 27, 2026
Key metrics
The numbers that frame NRXP today
- Market cap
- $131.51M
- P/E (TTM)
- -5.4
- EV / FCF
- -8.4
- Gross margin
- 50.5%
- EV / Sales
- 54.8
- ROIC
- 94.3%
- Div yield
- 0%
- 52wk Low
- $1.62
- 52wk High
- $5.06
Growth
Revenue and earnings trend for NRXP
RevenueNet income
See the full growth breakdown
Revenue and earnings trends, margins and the multi-year trajectory - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inCash flow & returns
Free cash flow and financial health
Free cash flowNet debt
See the full cash-flow picture
Free cash flow detail, returns on capital and the balance-sheet trend - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inInsider trading
Recent insider buying and selling activity
PurchasesSales
Unlock every insider trade
See who is buying and selling, how much, and when - updated as new filings land.
Create a free accountFree foreverNo card required
Already a member? Log inFrequently asked questions
Plain-English answers about NRXP
Is Nrx Pharmaceuticals a good buy?
No. Nrx Pharmaceuticals has excellent momentum, but poor quality undercuts the setup. Growth looks poor. That could put pressure on the long-term business case. We think Nrx Pharmaceuticals is selling at a very high price.
What is the market capitalization of NRXP?
Nrx Pharmaceuticals's market capitalization is $131.51M.
What is the P/E ratio for NRXP stock?
Nrx Pharmaceuticals's current P/E ratio is -5.4.
What is the 52-week high for NRXP stock?
The 52-week high for Nrx Pharmaceuticals is $5.06. The current close of $3.63 is 28.2% below that high.
What is the 52-week low for NRXP stock?
The 52-week low for Nrx Pharmaceuticals is $1.62. The current close of $3.63 is 124.1% above that low.
Does NRXP stock pay dividends?
Nrx Pharmaceuticals does not currently show a dividend per share in the company data.